BHC
Bausch Health Cos Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Bausch Health Cos Inc
Bausch Health Companies Inc.
8.20
No changes.
No changes.
| Manager | Value | % base | |
|---|---|---|---|
| Paulson | $361.2M | 29.30% | 0.00% |
| Goldentree | $170.7M | 13.85% | 0.00% |
| Royal Bank of Canada | $53.4M | 4.33% | −4.67% |
| Healthcare of Ontario Pension Plan Trust Fund | $39.4M | 3.20% | 0.00% |
| Vanguardindex-like | $36.8M | 2.99% | +0.83% |
| Manager | Value | % base | |
|---|---|---|---|
| Paulson | $361.2M | 29.30% | 0.00% |
| Goldentree | $170.7M | 13.85% | 0.00% |
| Royal Bank of Canada | $53.4M | 4.33% | −4.67% |
| Healthcare of Ontario Pension Plan Trust Fund | $39.4M | 3.20% | 0.00% |
| Vanguardindex-like | $36.8M | 2.99% | +0.83% |
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Annual filing, not covered
Not parsed · ties from counterparty filings
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Annual filing, not covered
Not parsed · ties from counterparty filings
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Linked news
NewsClosest co-movers of Bausch Health Cos Inc; it has no SEC industry code.
Closest co-movers of Bausch Health Cos Inc; it has no SEC industry code.
Closest co-movers · 500d
BMYBristol Myers Squibb×0.19r 0.36WHDCactus×0.25r 0.32BAXBaxter International×0.23r 0.32CMCOExpected move
No implied move.
Bull2
Bear1